摘要
[目的]评估MRI对经肝动脉栓塞化疗(transcatheter arterial chemoembolization,TACE)治疗肝癌近期疗效随访的价值。[方法]回顾性分析肝癌手术切除后复发22例患者(36个病灶)经TACE治疗后的MRI表现。[结果]MRI可正确判断22例患者(36个病灶)肝癌在TACE治疗后的近期疗效。随访1年,肿瘤完全凝固坏死32个,残留癌灶4个,2例患者在TACE治疗后1～3个月出现复发。[结论]MRI能准确评估TACE治疗肝癌的近期疗效。
[Purpose] To explore the role of MR imaging in evaluating short-term response in patients with hepatocellular carcinoma treated with transcatheter arterial chemoembolization （TACE）. [Methods] MR imaging findings in 22 patients （36 lesions） with recurrent hepatocellular carcinoma after surgical resection undergoing TACE were analyzed retrospectively. [Results] TACE correctly assessed short-term response in 22 patients with 36 HCC lesions were evaluated correctly. Of the 36 lesions with 1 year fol-low-up,32 lesions demonstrated complete coagulation necrosis and 4 residual lesions. The recurrent tu-mor occurred in 2 patients in 1 ～3 months after TACE. [Conclusions] MRI can accurately evaluate short-term response of TACE.
出处
《肿瘤学杂志》
CAS
2010年第7期558-560,共3页
Journal of Chinese Oncology
基金
军队"十一五"面上项目(06MA249)
关键词
磁共振成像
肝动脉栓塞化疗
肝肿瘤
magnetic resonance imaging
transcatheter arterial chemoembolization
liver neoplasms
